Cardiawave logo

Cardiawave

Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis.

33 employees · est. 2014 · Levallois-perret, France

VS
JenaValve Technology, Inc. logo

JenaValve Technology, Inc.

Aortic regurgitation is different. So is our valve.

149 employees · est. 2013 · Irvine, United States

JenaValve Technology, Inc. is the older company (2014 vs 2013); JenaValve Technology, Inc. is the larger of the two.

Side-by-Side Comparison

Cardiawave JenaValve Technology, Inc.
Founded
2014 2013 older
Headquarters
Levallois-perret, France Irvine, United States
Employees
33 149 larger
Industry
Health Care, Medical Devices Health Care, Manufacturing, Medical Devices
Funding Stage
Grant Series C
Total Funding
$13.31M $337.88M
Funding Rounds
6 11
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Medical Device, Non-invasive Treatment, Aortic Valve Stenosis, Ultrasound Therapy, Clinical-stage Startup, Innovative Technology, Image-guided Therapy, Langevin Institute, Georges Pompidou European Hospital, Cardiovascular Health, Award-winning, Partnership, Biomedical Engineering Transcatheter Heart Valve, Aortic Regurgitation, TAVR, Cardiovascular Treatment, Minimally Invasive Surgery, CE Mark, IDE Clinical Trial, PMA Submission, Health Technology, High-Risk Patients, Cardiovascular Innovation, International Headquarters, Innovative Medical Solutions
Website
cardiawave.com jenavalve.com
Cardiawave logo

About Cardiawave

Cardiawave is a clinical-stage company founded in 2014 and based in France, aiming to combat aortic valve stenosis, a life-threatening condition affecting approximately 10 million people in Western countries. The company has attracted attention by winning multiple innovation prizes and is backed by...

JenaValve Technology, Inc. logo

About JenaValve Technology, Inc.

JenaValve Technology, Inc. is a medical device company focused on developing the first transcatheter heart valve technology specifically designed for the minimally invasive treatment of aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System has gained approval in the EU for treating sev...

We will tell you when either one moves

BounceWatch watches Cardiawave and JenaValve Technology, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cardiawave and JenaValve Technology,... — by email.

Frequently Asked Questions

Cardiawave — Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis.. JenaValve Technology, Inc. — Aortic regurgitation is different. So is our valve.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cardiawave has raised $13.31M while JenaValve Technology, Inc. has raised $337.88M.
Cardiawave and JenaValve Technology, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cardiawave with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cardiawave on 11 Sep 2024, and JenaValve Technology, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy